Mitomycin and Cardiac failure - a phase IV clinical study of FDA data

Summary:

Cardiac failure is reported as a side effect among people who take Mitomycin (mitomycin), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Fluorouracil, and have Cardiogenic shock.

The phase IV clinical study analyzes which people have Cardiac failure when taking Mitomycin. It is created by eHealthMe based on reports of 4,183 people who have side effects when taking Mitomycin from the FDA, and is updated regularly.

What is Mitomycin?

Mitomycin has active ingredients of mitomycin. eHealthMe is studying from 4,195 Mitomycin users. Check the latest studies of Mitomycin.

What is Cardiac failure?

Cardiac failure is found to be associated with 2,056 drugs and 2,210 conditions by eHealthMe. Check the latest studies of Cardiac failure.

On Jul, 26, 2026

4,183 people reported to have side effects when taking Mitomycin.
Among them, 36 people (0.86%) have Cardiac failure.

Among these 36 people:

How long have people been on Mitomycin when they have Cardiac failure? *

What is the gender of people who have Cardiac failure when taking Mitomycin? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Cardiac failure when taking Mitomycin? *

What are other drugs people take besides Mitomycin? *

What are other side effects people have besides Cardiac failure? *

Acute Kidney Failure: 5 people, 13.89%
Diarrhea: 4 people, 11.11%
Interstitial Lung Disease: 4 people, 11.11%
Pleural Effusion (water on the lungs): 4 people, 11.11%
Cardiogenic Shock (inadequate circulation of blood): 4 people, 11.11%
Abdominal Distension: 3 people, 8.33%
Hypotension (abnormally low blood pressure): 3 people, 8.33%
Hypoperfusion (decreased blood flow through an organ): 3 people, 8.33%
Pulmonary Oedema (fluid accumulation in the lungs): 3 people, 8.33%
Fever: 3 people, 8.33%

What are the existing conditions these people have? *

Colon Cancer: 4 people, 11.11%
Cardiogenic Shock (inadequate circulation of blood): 4 people, 11.11%
Neoplasm Malignant (cancer tumour): 3 people, 8.33%
Carcinoid Syndrome (syndrome includes flushing and diarrhoea, and, less frequently, heart failure and bronchoconstriction): 3 people, 8.33%
Anal Cancer: 3 people, 8.33%
Neuroendocrine Tumor: 2 people, 5.56%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 5.56%
Malignant Peritoneal Neoplasm (cancer tumour of peritoneum): 2 people, 5.56%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 5.56%
Gastric Cancer (stomach cancer): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Mitomycin and have Cardiac failure?

- Check whether Cardiac failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mitomycin:

Mitomycin (4,195 reports)

Cardiac failure treatments and more:

Cardiac failure (147,157 reports)

Browse all side effects of Mitomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cardiac failure:

Cardiac failure (2,056 drugs)

Browse all the conditions that are associated with Cardiac failure:

Cardiac failure (2,210 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mitomycin (the active ingredients of Mitomycin) and Mitomycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.